Acute lower respiratory tract infection in primary care: improving prognosis by considering the interplay between the lung and the heart
Lower respiratory tract infections (LRTIs) may lead to serious complications, including hospitalisation, mortality and acute cardiovascular events. Early identification of patients at increased risk is therefore important in general practice.
Aim
This project investigated the prognosis of lower respiratory tract infections in primary care.
Approach
Using routinely collected electronic health record data linked to hospital admission and mortality data, we developed and externally validated a prediction model for hospitalisation or death within 30 days after an LRTI. We also investigated the risk of acute cardiovascular events during and shortly after an LRTI and evaluated the use of natural language processing of free-text electronic health records for prognostic research.
Results
- The developed prediction model is promising to support general practitioners in estimating the prognosis of patients with an LRTI.
- In addition, the risk of acute cardiovascular events—including myocardial infarction, stroke, transient ischaemic attack, pulmonary embolism, deep venous thrombosis and atrial fibrillation—was highest during the first week after an LRTI and remained increased for 1 to 3 months.
- The project also demonstrated that language models can be used to retrieve information from free-text electronic health records for scientific research.
Recommendations
- Currently available prediction models for hospitalisation or mortality after LRTI are not suitable for implementation in everyday general practice and should be further evaluated and improved.
- Future research should evaluate whether the newly developed and externally validated prediction model improves patient outcomes in routine primary care.
- Develop interventions, together with patients and general practitioners, aimed at early detection and/or prevention of acute cardiovascular events following LRTI, while promoting uptake of seasonal vaccination against important respiratory pathogens.
Products
Author: la Roi-Teeuw HM, van Smeden M, Bos M, de Wilde SM, Yang B, Rutten FH, Geersing GJ.
Magazine: Open Heart
Author: Rijk MH, Platteel TN, Mulder MMM, Geersing GJ, Rutten FH, van Smeden M, Venekamp RP, Leeuwenberg TM
Magazine: J Clin Epidemiol. 2024 Feb;166:111240
Author: Jukema BN, Smit K, Hopman MTE, Bongers CCWG, Pelgrim TC, Rijk MH, Platteel TN, Venekamp RP, Zwart DLM, Rutten FH, Koenderman L
Magazine: Frontiers in Allergy.
Link: https://www.frontiersin.org/articles/10.3389/falgy.2022.942699/full
Author: la Roi-Teeuw HM, van Smeden M, Geersing GJ, Klungel OH, Rutten FH, Souverein PC, van Doorn S.
Magazine: Eur Heart J Open
Author: la Roi-Teeuw HM, van Smeden M, Geersing GJ, Klungel OH, Rutten FH, Souverein PC, van Doorn S
Magazine: Eur Heart J Open. 2023 Sep 28;3(6):oead101
Author: Rijk MH, Platteel TN, Mulder MMM, Geersing GJ, Rutten FH, van Smeden M, Venekamp RP, Leeuwenberg TM
Magazine: J Clin Epidemiol. 2024 Feb;166:111240
Author: la Roi-Teeuw HM, van Smeden M, Geersing GJ, Klungel OH, Rutten FH, Souverein PC, van Doorn S.
Magazine: Eur Heart J Open. 2023
Author: Rijk MH, Platteel TN, Geersing GJ, Hollander M, Dalmolen BLGP, Little P, Rutten FH, van Smeden M, Venekamp RP.
Magazine: Diagn Progn Res. 2023 Dec 7;7(1):23
Author: la Roi-Teeuw HM, van Smeden M, Geersing GJ, Klungel OH, Rutten FH, Souverein PC, van Doorn S
Magazine: EHJ Open
Author: Rijk MH, Platteel TN, van den Berg TMC, et al
Magazine: BMJ open
Author: la Roi-Teeuw HM, van Smeden M, Bos M, de Wilde SM, Yang B, Rutten FH, Geersing GJ
Magazine: Open Heart. 2023 Nov 28;10(2):e002501
Author: Rijk MH, Platteel TN, Geersing GJ, Hollander M, Dalmolen BLGP, Little P, Rutten FH, van Smeden M, Venekamp RP
Magazine: Diagn Progn Res.
Author: Jukema BN, Smit K, Hopman MTE, Bongers CCWG, Pelgrim TC, Rijk MH, Platteel TN, Venekamp RP, Zwart DLM, Rutten FH, Koenderman L.
Magazine: Frontiers in Allergy